Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

New strategies in the treatment of early Parkinson's disease

Identifieur interne : 002693 ( Main/Exploration ); précédent : 002692; suivant : 002694

New strategies in the treatment of early Parkinson's disease

Auteurs : U. K. Rinne [Finlande]

Source :

RBID : ISTEX:606CF73F0EA47D7B6C3F1CDA414B291234905B43

English descriptors

Abstract

Over recent years I have been studying whether dopamine agonist treatment alone, or in early combination with levodopa, might institute a better long‐term treatment in Parkinson's disease than levodopa alone. Indeed, early combination of levodopa with bromocriptine, pergolide or lisuride has indicated that this kind of treatment results in better management of Parkinson's disease with fewer fluctuations in disability, especially end‐of‐dose disturbances and dyskinesias, than treatment with levodopa alone. Furthermore, similar results were obtained by using lisuride in combination with selegiline and levodopa. However, during long‐term treatment the changes in parkinsonian disability were equal in all treatment groups with or without selegiline. Thus, the possible efficacy of selegiline in slowing down the progression of Parkinson's disease requires further investigations. As a new treatment strategy it appears advisable to initiate the dopaminergic treatment in early Parkinson's disease by using initially selegiline and a dopamine agonist and by adding levodopa when the therapeutic response is insuifficient. Another alternative would be to start with selegiline alone, then add a dopamine agonist and, finally, levodopa.

Url:
DOI: 10.1111/j.1600-0404.1991.tb05028.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">New strategies in the treatment of early Parkinson's disease</title>
<author>
<name sortKey="Rinne, U K" sort="Rinne, U K" uniqKey="Rinne U" first="U. K." last="Rinne">U. K. Rinne</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:606CF73F0EA47D7B6C3F1CDA414B291234905B43</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1111/j.1600-0404.1991.tb05028.x</idno>
<idno type="url">https://api.istex.fr/document/606CF73F0EA47D7B6C3F1CDA414B291234905B43/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002C19</idno>
<idno type="wicri:Area/Main/Curation">002850</idno>
<idno type="wicri:Area/Main/Exploration">002693</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">New strategies in the treatment of early Parkinson's disease</title>
<author>
<name sortKey="Rinne, U K" sort="Rinne, U K" uniqKey="Rinne U" first="U. K." last="Rinne">U. K. Rinne</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Neurology, University of Turku, Turku</wicri:regionArea>
<placeName>
<settlement type="city">Turku</settlement>
<region type="région" nuts="2">Finlande occidentale</region>
</placeName>
<orgName type="university">Université de Turku</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Acta Neurologica Scandinavica</title>
<idno type="ISSN">0001-6314</idno>
<idno type="eISSN">1600-0404</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1991-10">1991-10</date>
<biblScope unit="volume">84</biblScope>
<biblScope unit="issue">S136</biblScope>
<biblScope unit="page" from="95">95</biblScope>
<biblScope unit="page" to="98">98</biblScope>
</imprint>
<idno type="ISSN">0001-6314</idno>
</series>
<idno type="istex">606CF73F0EA47D7B6C3F1CDA414B291234905B43</idno>
<idno type="DOI">10.1111/j.1600-0404.1991.tb05028.x</idno>
<idno type="ArticleID">ANE95</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0001-6314</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson's disease</term>
<term>dopamine agonist</term>
<term>early treatment</term>
<term>levodopa</term>
<term>new strategies</term>
<term>selegiline</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Over recent years I have been studying whether dopamine agonist treatment alone, or in early combination with levodopa, might institute a better long‐term treatment in Parkinson's disease than levodopa alone. Indeed, early combination of levodopa with bromocriptine, pergolide or lisuride has indicated that this kind of treatment results in better management of Parkinson's disease with fewer fluctuations in disability, especially end‐of‐dose disturbances and dyskinesias, than treatment with levodopa alone. Furthermore, similar results were obtained by using lisuride in combination with selegiline and levodopa. However, during long‐term treatment the changes in parkinsonian disability were equal in all treatment groups with or without selegiline. Thus, the possible efficacy of selegiline in slowing down the progression of Parkinson's disease requires further investigations. As a new treatment strategy it appears advisable to initiate the dopaminergic treatment in early Parkinson's disease by using initially selegiline and a dopamine agonist and by adding levodopa when the therapeutic response is insuifficient. Another alternative would be to start with selegiline alone, then add a dopamine agonist and, finally, levodopa.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
</country>
<region>
<li>Finlande occidentale</li>
</region>
<settlement>
<li>Turku</li>
</settlement>
<orgName>
<li>Université de Turku</li>
</orgName>
</list>
<tree>
<country name="Finlande">
<region name="Finlande occidentale">
<name sortKey="Rinne, U K" sort="Rinne, U K" uniqKey="Rinne U" first="U. K." last="Rinne">U. K. Rinne</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002693 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002693 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:606CF73F0EA47D7B6C3F1CDA414B291234905B43
   |texte=   New strategies in the treatment of early Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024